The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.

Two faculty members of the Vanderbilt Memory and Alzheimer’s Center are among a handful of 2015 scholars for the Paul B. Beeson Career Development Awards in Aging Research Program.

Three Nigerian physicians who survived Ebola virus disease in July 2014 after coming in direct contact with an Ebola-infected patient will speak at Vanderbilt University Medical Center next Wednesday, Sept. 16.

Understanding the action of a certain enzyme will shed light on basement membrane function, and on disorders ranging from diabetic kidney disease to cancer.

Vanderbilt was ranked No. 15 on "U.S. News & World Report's" list of top national universities, its best-ever showing.

Understanding how macrophage immune cells accumulate in fat tissue and contribute to the pathology of obesity could lead to the development of novel therapeutics for metabolic disorders.

Dietary vitamin C may maintain healthy blood vessels in patients with inflammatory diseases.